No abstract

Leucoreduction of RBC before storage helps to preserve the activity of antioxidant barrier enzymes in stored RBCs and significantly improves the quality of stored red blood cell components.

Autohemotherapy with ozonated blood is used in the treatment of a broad spectrum of clinical disorders. Ozone demonstrates strong oxidizing properties and causes damage to cell membranes. The impact of whole-blood ozonation on the release of microparticles from blood and endothelial cells and the concentration of selected markers in the hemostatic system (APTT, PT, D-dimer, fibrinogen) were investigated. Venous blood, obtained from 19 healthy men, was split into four equal parts and treated with air, 15 µg/mL ozone, or 30 µg/mL ozone, or left untreated. The number and types of microparticles released were determined using flow cytometry on the basis of surface antigen expression: erythrocyte-derived microparticles (CD235+), platelet-derived microparticles (CD42+), leukocyte-derived microparticles (CD45+), and endothelial-derived microparticles (CD144+). The study is the first to demonstrate that ozone induces a statistically significant increase in the number of microparticles derived from blood and endothelial cells. Although statistically significant, the changes in some coagulation factors were somewhat mild and did not exceed normal values.

Public and third sector employees are facing increasing pressure to behave more entrepreneurially in their day-to-day work (Wakkee, Elfring and Monaghan, 2010). Literature on entrepreneurial orientation (EO) highlighted that EO enhances organisational performance, firms' competiveness and product innovation (Rauch et al., 2009;Lumpkin and Dess, 2001). While previous studies on EO have applied the concept in relation to the overall performance of an organisation (Wiklund and Shepherd, 2005), this research explores EO at the individual level (Jelenc, Pisapia and Ivanušić, 2015;Bolton and Lane, 2012;Okhomina, 2010

Highlights Pathogen reduction can be an effective method of reducing emerging infectious agents. Assessment of the effectiveness of pathogen reduction against SARS-CoV-2 is required. The timing of pathogen reduction should be adapted to the actual plasma demand. Pathogen reduction performed post thawing may ensure safe plasma for transfusion. Pathogen reduction techniques can solve the issue of plasma from one-time-only donors.